Research
Good Bacteria
Part 1

Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model

Abstract

Kim H, Kwack K, Kim DY, Ji GE.

Department of Food and Nutrition, Seoul National University, San 56-1, Shillim-Dong, Kwanak-Ku, Seoul 151-742, Republic of Korea.

This study investigated whether orally administered probiotic bacteria (Bifidobacterium bifidum and Lactobacillus casei) and a gram-negative bacterium (Escherichia coli) function as allergic immune modulators to prevent food allergy, according to the hygiene hypothesis. C3H/HeJ mice were sensitized with ovalbumin (OVA) and cholera toxin for 5 weeks. After sensitization, the OVA-induced mice that were not treated with bacteria had significantly increased levels of OVA-specific IgE, total IgE, and IgG1 in sera, as well as scab-covered tails. In comparison, groups treated with B. bifidum BGN4 (BGN4), L. casei 911 (L. casei), or Escherichia coli MC4100 (E. coli) had decreased levels of OVA-specific IgE, total IgE, and IgG1, and decreased levels of mast cell degranulation and tail scabs. OVA-specific IgA levels were decreased in BGN4- and L. casei-treated groups. In conclusion, administration of E. coli, BGN4, or L. casei decreased the OVA-induced allergy response. However, a normal increase in body weight was inhibited in the E. coli-treated mice and in the montreated mice groups during allergy sensitization. Thus, BGN4 and L. casei appear to be useful probiotic bacteria for the prevention of allergy.

Reference:

FEMS Immunol Med Microbiol. 2005 Aug 1;45(2):259-67

Next - Back to Table of Contents for Good Bacteria, Part 1